1. Genet Med. 2019 Dec;21(12):2713-2722. doi: 10.1038/s41436-019-0557-3. Epub
2019  Jun 3.

Variants in MED12L, encoding a subunit of the mediator kinase module, are 
responsible for intellectual disability associated with transcriptional defect.

Nizon M(1)(2), Laugel V(3), Flanigan KM(4), Pastore M(4), Waldrop MA(4), 
Rosenfeld JA(5), Marom R(5), Xiao R(5), Gerard A(5), Pichon O(6), Le Caignec 
C(6), Gérard M(7), Dieterich K(8), Truitt Cho M(9), McWalter K(9), Hiatt S(10), 
Thompson ML(10), Bézieau S(6)(11), Wadley A(12), Wierenga KJ(13), Egly JM(14), 
Isidor B(6)(11).

Author information:
(1)CHU Nantes, Service de Génétique Médicale, Nantes, France. 
bertrand.isidor@chu-nantes.fr.
(2)L'institut du thorax, INSERM, CNRS, UNIV Nantes, 44007, Nantes, France. 
bertrand.isidor@chu-nantes.fr.
(3)Laboratoire de génétique médicale, INSERM UMR 1112, Faculté de Médecine, 11 
rue Humann, 67000, Strasbourg, France.
(4)Neurology Department, Nationwide Children's Hospital, Columbus, OH, USA.
(5)Baylor College of Medicine, Houston, TX, USA.
(6)CHU Nantes, Service de Génétique Médicale, Nantes, France.
(7)Service de Génétique Clinique, CHU Caen, Caen, France.
(8)Service de Génétique Clinique, CHU Grenoble, Grenoble, France.
(9)Clinical Genomics GeneDx, Gaithersburg, MD, USA.
(10)HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
(11)L'institut du thorax, INSERM, CNRS, UNIV Nantes, 44007, Nantes, France.
(12)University of Oklahoma School of Medicine, Oklahoma City, OK, USA.
(13)Mayo Clinic Florida, Jacksonville, FL, 32224, USA.
(14)Institut de génétique et de biologie moléculaire cellulaire IGBMC, Faculté 
de Médecine, Strasbourg, France.

Erratum in
    Genet Med. 2019 Nov;21(11):2663. doi: 10.1038/s41436-019-0590-2.

Comment in
    Genet Med. 2022 Oct;24(10):2204-2205. doi: 10.1016/j.gim.2022.05.019.

PURPOSE: Mediator is a multiprotein complex that allows the transfer of genetic 
information from DNA binding proteins to the RNA polymerase II during 
transcription initiation. MED12L is a subunit of the kinase module, which is one 
of the four subcomplexes of the mediator complex. Other subunits of the kinase 
module have been already implicated in intellectual disability, namely MED12, 
MED13L, MED13, and CDK19.
METHODS: We describe an international cohort of seven affected individuals 
harboring variants involving MED12L identified by array CGH, exome or genome 
sequencing.
RESULTS: All affected individuals presented with intellectual disability and/or 
developmental delay, including speech impairment. Other features included autism 
spectrum disorder, aggressive behavior, corpus callosum abnormality, and mild 
facial morphological features. Three individuals had a MED12L deletion or 
duplication. The other four individuals harbored single-nucleotide variants (one 
nonsense, one frameshift, and two splicing variants). Functional analysis 
confirmed a moderate and significant alteration of RNA synthesis in two 
individuals.
CONCLUSION: Overall data suggest that MED12L haploinsufficiency is responsible 
for intellectual disability and transcriptional defect. Our findings confirm 
that the integrity of this kinase module is a critical factor for neurological 
development.

DOI: 10.1038/s41436-019-0557-3
PMCID: PMC7243155
PMID: 31155615 [Indexed for MEDLINE]

Conflict of interest statement: The other authors declare no conflict of 
interest.